Our research, conducted on ER(+) MCF7 and ER(−) MDA-MB-231 breast cancer cells and non-tumorigenic breast MCF10A cells, has shown that resveratrol modulated the expression of CYP19. This evidence concerns the gene ESR1 and breast carcinoma.